Tags:AnalyticsArtificial IntelligenceClinicDiagnosticsHealthTechInformationITLearnPlatformTechnology
Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform [www.cernostics.com] and how it will change the future of cancer diagnostics.
Location: United States, Pennsylvania, Pittsburgh
Member count: 11-50
Total raised: $9.055M
Founded date: 2008

Investors 1

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
21.03.2018-$2.5M-citybizlis...
31.08.2016-$5M-hitconsult...
04.12.2013Series B$1.4M-finsmes.co...
09.08.2012-$100K-finsmes.co...
08.03.2012-$55K-finsmes.co...

Mentions in press and media 22

DateTitleDescriptionCategoryAuthorSource
22.10.2021Biotech fi...As momentum builds for Pittsbu...--technical....
11.08.2020Is Pittsbu...Stephanie Kladakis grew up in ...--technical....
22.03.2018Term Sheet...THE VC WAR CHEST Good morning...--fortune.co...
22.03.2018Cernostics...Cernostics, a Pittsburgh, PA-b...-Fred Penni...hitconsult...
21.03.2018Cernostics...Cernostics, a privately-held c...--citybizlis...
21.03.2018Cernostics...Cernostics, a Pittsburgh, PA-b...USA-finsmes.co...
06.09.2016Backed by ...Cernostics, a Pittsburgh, PA-b...-HITC Staffhitconsult...
06.09.2016UPMC backs...This recent infusion of cash w...--medcitynew...
31.08.2016Cernostics...Cernostics, a Pittsburgh and B...USA-finsmes.co...
31.08.2016Cernostics...As part of its wide-ranging ef...--citybizlis...
Show more